Boston Trust Walden’s Xylem XYL Stock Holding History

Boston Trust Walden’s Portfolio XYL Stock Details XYL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$914K	Buy	7,732 +210	+3%	+$24.2K	0.01%	299
2026 Q1	$899K	Sell	7,522 -20	-0.3%	-$2.62K	0.01%	292
2025 Q4	$1.03M	Buy	7,542 +3,810	+102%	+$548K	0.01%	276
2025 Q3	$550K	Buy	3,732 +30	+0.8%	+$4.16K	﹤0.01%	323
2025 Q2	$479K	Sell	3,702 -16	-0.4%	-$1.94K	﹤0.01%	321
2025 Q1	$444K	Buy	3,718 +300	+9%	+$37.2K	﹤0.01%	321
2024 Q4	$397K	Hold	3,418	–	–	﹤0.01%	330
2024 Q3	$462K	Hold	3,418	–	–	﹤0.01%	322
2024 Q2	$464K	Hold	3,418	–	–	﹤0.01%	325
2024 Q1	$442K	Hold	3,418	–	–	﹤0.01%	327
2023 Q4	$391K	Buy	3,418 +107	+3%	+$10.7K	﹤0.01%	322
2023 Q3	$301K	Hold	3,311	–	–	﹤0.01%	334
2023 Q2	$373K	Hold	3,311	–	–	﹤0.01%	326
2023 Q1	$347K	Hold	3,311	–	–	﹤0.01%	330
2022 Q4	$366K	Hold	3,311	–	–	﹤0.01%	327
2022 Q3	$289K	Hold	3,311	–	–	﹤0.01%	329
2022 Q2	$259K	Hold	3,311	–	–	﹤0.01%	344
2022 Q1	$282K	Hold	3,311	–	–	﹤0.01%	355
2021 Q4	$397K	Buy	3,311 +295	+10%	+$36.6K	﹤0.01%	345
2021 Q3	$373K	Hold	3,016	–	–	﹤0.01%	339
2021 Q2	$362K	Hold	3,016	–	–	﹤0.01%	344
2021 Q1	$317K	Hold	3,016	–	–	﹤0.01%	341
2020 Q4	$307K	Hold	3,016	–	–	﹤0.01%	346
2020 Q3	$254K	Buy	+3,016	New	+$235K	﹤0.01%	350
2020 Q1	–	Sell	-3,016	Closed	-$238K	–	382
2019 Q4	$238K	Hold	3,016	–	–	﹤0.01%	367
2019 Q3	$240K	Hold	3,016	–	–	﹤0.01%	365
2019 Q2	$252K	Hold	3,016	–	–	﹤0.01%	362
2019 Q1	$238K	Hold	3,016	–	–	﹤0.01%	363
2018 Q4	$201K	Hold	3,016	–	–	﹤0.01%	369
2018 Q3	$241K	Hold	3,016	–	–	﹤0.01%	364
2018 Q2	$203K	Hold	3,016	–	–	﹤0.01%	373
2018 Q1	$232K	Hold	3,016	–	–	﹤0.01%	372
2017 Q4	$206K	Buy	+3,016	New	+$200K	﹤0.01%	378

Other funds holding XYL

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

AIM

Achmea Investment Management Zeist, Netherlands $4B AUM 31.99% 1-Year Est. Return

CTB

Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Boston Trust Walden's XYL Position: Q2 2026 in Review

Boston Trust Walden increased its Xylem (XYL) stake by 2.8% in Q2 2026, buying an estimated $24.2K and bringing the position to 7,732 shares worth $914K. The position accounts for 0.01% of the portfolio, ranked #299.

Boston Trust Walden first reported a position in XYL in Q4 2017 and has held it in 33 quarters since. The position peaked at $1.03M in Q4 2025. 399 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

Boston Trust Walden held 7,732 shares of Xylem worth $914K as of Q2 2026.
Boston Trust Walden bought 210 Xylem shares in Q2 2026, an estimated $24.2K.
Xylem made up 0.01% of Boston Trust Walden's portfolio in Q2 2026, its #299 holding.
Boston Trust Walden first reported a position in Xylem in Q4 2017 and has held it in 33 quarters since.
Boston Trust Walden's Xylem position peaked at $1.03M in Q4 2025.
399 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Boston Trust Walden's 13F filing for Q2 2026, filed 24 Jul 2026.